Molecular β-adrenergic signaling abnormalities in failing rabbit hearts after infarction.
暂无分享,去创建一个
D. Glower | W. Koch | A. Shah | A. Kypson | D. C. White | J. A. Hata | Ashish S. Shah | J. P. Maurice
[1] Robert,et al. The Binding Site for the @ r Subunits of Heterotrimeric G Proteins on the @-Adrenergic Receptor Kinase * , 2001 .
[2] ICHAEL,et al. THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE , 2000 .
[3] R. Lefkowitz,et al. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. , 1998, Circulation.
[4] J. Ross,et al. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Lefkowitz,et al. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Goldman,et al. Echocardiographic changes after myocardial infarction in a model of left ventricular diastolic dysfunction. , 1997, American journal of physiology. Heart and circulatory physiology.
[7] P. Ping,et al. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. , 1997, The American journal of physiology.
[8] W. Koch,et al. Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase* , 1997, The Journal of Biological Chemistry.
[9] R. Lefkowitz,et al. Gene transfer strategies for augmenting cardiac function. , 1997, Trends in cardiovascular medicine.
[10] J. Ross,et al. Animal models of heart failure recent developments and perspectives. , 1997, Trends in cardiovascular medicine.
[11] M. Drazner,et al. Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. , 1997, The Journal of clinical investigation.
[12] R. Lefkowitz,et al. Restoration of b-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer , 1997 .
[13] R. Lefkowitz,et al. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Lohse,et al. Activation of β-Adrenergic Receptor Kinase During Myocardial Ischemia , 1996 .
[15] K. Swedberg,et al. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction. , 1996, American heart journal.
[16] R. Lefkowitz,et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.
[17] R. S. Williams. Boosting cardiac contractility with genes. , 1995, The New England journal of medicine.
[18] K. Mahaffey,et al. Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue. , 1995, Circulation.
[19] J. Port,et al. Reduced beta 1 receptor messenger RNA abundance in the failing human heart. , 1993, The Journal of clinical investigation.
[20] R. Lefkowitz,et al. Structure and mechanism of the G protein-coupled receptor kinases. , 1993, The Journal of biological chemistry.
[21] M. Bristow. Changes in myocardial and vascular receptors in heart failure. , 1993, Journal of the American College of Cardiology.
[22] R. Lefkowitz,et al. The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. , 1993, The Journal of biological chemistry.
[23] M. Böhm,et al. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. , 1993, Circulation.
[24] M. Lohse,et al. Altered Expression of, ‐Adrenergic Receptor Kinase and 1‐Adrenergic Receptors in the Failing Human Heart , 1993 .
[25] O. Brodde. Beta-adrenoceptors in cardiac disease. , 1993, Pharmacology & therapeutics.
[26] J. B. Higgins,et al. Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. , 1992, Science.
[27] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[28] J. Port,et al. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. , 1989, Molecular pharmacology.
[29] W. Baumgartner,et al. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.
[30] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.